Control of feeding behavior in C. elegans by human G protein-coupled receptors permits screening for agonist-expressing bacteria

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 39, 2008, Pages 14826-14831

  Teng, Michelle S ^a   Shadbolt, Paul ^b   Fraser, Andrew G ^a   Jansen, Gert ^c   McCafferty, John ^b  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CCR5; MIP 1

Indexed keywords

CHEMOKINE RECEPTOR CCR5; G PROTEIN COUPLED RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; LIGAND;

ARTICLE; AVOIDANCE BEHAVIOR; CAENORHABDITIS ELEGANS; CALCIUM TRANSPORT; CONTROLLED STUDY; ESCHERICHIA COLI; FEEDING BEHAVIOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SCREENING; TRANSGENICS; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DRUG ANTAGONISM; DRUG POTENTIATION; GENE LIBRARY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; NERVE CELL; PHYSIOLOGY; PROTEIN BINDING; PROTEIN CONFORMATION; TRANSGENE; TRANSGENIC ANIMAL;

BACTERIA (MICROORGANISMS); CAENORHABDITIS ELEGANS; ESCHERICHIA COLI; MAMMALIA;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CAENORHABDITIS ELEGANS; CHEMOKINE CCL3; ESCHERICHIA COLI; FEEDING BEHAVIOR; GENE LIBRARY; HUMANS; LIGANDS; NEURONS; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, CCR5; RECEPTORS, G-PROTEIN-COUPLED; TRANSGENES;

EID: 54449083070     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0803290105     Document Type: Article

References (39)

1. Teng MS, et al. (2006) Expression of mammalian GPCRs in C. elegans generates novel behavioural responses to human ligands. BMC Biol 4:22.
2. Shtonda BB, Avery L (2006) Dietary choice behavior in Caenorhabditis elegans. J Exp Biol 209:89-102.
3. Hunter MG, et al. (1995) BB-10010: An active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties. Blood 86:4400-4408.
4. Czaplewski LG, et al. (1999) Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES Characterization of active disaggregated chemokine variants. J Biol Chem 274:16077-16084.
5. Mueller A, Mahmoud NG, Strange PG (2006) Diverse signalling by different chemokines through the chemokine receptor CCR5. Biochem Pharmacol 72:739-748.
6. Clark-Lewis I, et al. (1995) Structure-activity relationships of chemokines. J Leukocyte Biol 57:703-711.
7. Cunningham BC, Wells JA (1989) High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 244:1081-1085.
8. Wells JA (1991) Systematic mutational analyses of protein-protein interfaces. Methods Enzymol 202:390-411.
9. Stables J, et al. (1997) A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal Biochem 252:115-126.
10. Detheux M, et al. (2000) Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties. J Exp Med 192:1501-1508.
11. Bondue A, et al. (2002) Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding. Biochemistry 41:13548-13555.
12. Laurence JS, et al. (2000) CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding. Biochemistry 39:3401-3409.
13. Gong JH, et al. (1996) RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem 271:10521-10527.
14. Gong JH, Clark-Lewis I (1995) Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues. J Exp Med 181:631-640.
15. Pakianathan DR, et al. (1997) Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. Biochemistry 36:9642-9648.
16. Weber M, et al. (1996) Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J Exp Med 183:681-685.
17. LiWang AC, et al. (1999) Dynamics study on the anti-human immunodeficiency virus chemokine viral macrophage-inflammatory protein-II (VMIP-II) reveals a fully monomeric protein. Biochemistry 38:442-453.
18. Kim S, Jao S, Laurence JS, LiWang PJ (2001) Structural comparison of monomeric variants of the chemokine MIP-1beta having differing ability to bind the receptor CCR5. Biochemistry 40:10782-10791.
19. Lee B, et al. (1999) Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J Biol Chem 274:9617-9626.
20. Samson M, et al. (1997) The second extracellular loop of CCR5 is the major determinant of ligand specificity. J Biol Chem 272:24934-24941.
21. Wu L, et al. (1997) Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med 186:1373-1381.
22. Dragic T, et al. (1998) Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J Virol 72:279-285.
23. Blanpain C, et al. (1999) Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein. J Biol Chem 274:34719-34727.
24. Laurence JS, et al. (2001) Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions. Biochemistry 40:4990-4999.
25. Koopmann W, Ediriwickrema C, Krangel MS (1999) Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta. J Immunol 163:2120-2127.
26. Kwok TC, et al. (2006) A small-molecule screen in C. elegans yields a new calcium channel antagonist. Nature 441:91-95.
27. Jones AK, Buckingham SD, Sattelle DB (2005) Chemistry-to-gene screens in Caenorhabditis elegans. Nat Rev Drug Discov 4:321-330.
28. Segalat L (2007) Invertebrate animal models of diseases as screening tools in drug discovery. ACS Chem Biol 2:231-236.
29. Segalat L (2006) Drug discovery: Here comes the worm. ACS Chem Biol 1:277-278.
30. Spehr M, et al. (2003) Identification of a testicular odorant receptor mediating human sperm chemotaxis. Science 299:2054-2058.
31. Milani N, et al. (2002) Functional expression of a mammalian olfactory receptor in Caenorhabditis elegans. NeuroReport 13:2515-2520.
32. Armbruster BN, et al. (2007) Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc Natl Acad Sci USA 104:5163-5168.
33. Li B, et al. (2007) Rapid identification of functionally critical amino acids in a G protein-coupled receptor. Nat Methods 4:169-174.
34. Mello CC, Kramer JM, Stinchcomb D, Ambros V (1991) Efficient gene transfer in C.elegans: Extrachromosomal maintenance and integration of transforming sequences. EMBO J 10:3959-3970.
35. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77:71-94.
36. Martin CD, et al. (2006) A simple vector system to improve performance and utilisation of recombinant antibodies. BMC Biotechnol 6:46.
37. Kunkel TA, Roberts JD, Zakour RA (1987) Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 154:367-382.
38. Studier FW (2005) Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 41:207-234.
39. Blanpain C, et al. (1999) CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood 94:1899-1905.